[Treatment of severe cutaneous adverse drug reactions]. 2018

S Ingen-Housz-Oro, and T-A Duong, and N de Prost, and A Colin, and L Fardet, and B Lebrun-Vignes, and A Barbaud, and O Chosidow, and P Wolkenstein, and
Service de dermatologie, hôpital Henri-Mondor, AP-HP, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94000 Créteil, France; Centre de référence des dermatoses bulleuses toxiques et toxidermies graves (filière FIMARAD), hôpital Henri-Mondor, AP-HP, 51, avenue du Maréchal-de-Lattre-de-Tassigny, 94000 Créteil, France; FISARD (groupe toxidermies de la Société française de dermatologie), 10, cité Malesherbes, 75009 Paris, France. Electronic address: saskia.oro@aphp.fr.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D013262 Stevens-Johnson Syndrome Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis. Drug-Induced Stevens Johnson Syndrome,Drug-Induced Stevens-Johnson Syndrome,Epidermal Necrolysis, Toxic,Lyell's Syndrome,Mycoplasma-Induced Stevens Johnson Syndrome,Mycoplasma-Induced Stevens-Johnson Syndrome,Nonstaphylococcal Scalded Skin Syndrome,Scalded Skin Syndrome, Nonstaphylococcal,Stevens Johnson Syndrome Toxic Epidermal Necrolysis,Stevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,Stevens-Johnson Syndrome Toxic Epidermal Necrolysis,Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,Toxic Epidermal Necrolysis,Toxic Epidermal Necrolysis Stevens Johnson Syndrome,Toxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum,Toxic Epidermal Necrolysis Stevens-Johnson Syndrome,Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum,Drug Induced Stevens Johnson Syndrome,Drug-Induced Stevens-Johnson Syndromes,Epidermal Necrolyses, Toxic,Lyell Syndrome,Lyell's Syndromes,Mycoplasma Induced Stevens Johnson Syndrome,Necrolyses, Toxic Epidermal,Necrolysis, Toxic Epidermal,Stevens Johnson Syndrome,Stevens-Johnson Syndrome, Drug-Induced,Stevens-Johnson Syndrome, Mycoplasma-Induced,Stevens-Johnson Syndromes, Drug-Induced,Syndrome, Lyell's,Syndrome, Mycoplasma-Induced Stevens-Johnson,Syndromes, Lyell's,Toxic Epidermal Necrolyses
D063926 Drug Hypersensitivity Syndrome Severe drug eruption characterized by high fever, erythematous rash and inflammation of internal organ(s). Drug Reaction With Eosinophilia And Systemic Symptom,DRESS Syndrome,Drug Reaction with Eosinophilia and Systemic Symptoms,Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome,DRESS Syndromes,Drug Hypersensitivity Syndromes,Hypersensitivity Syndrome, Drug,Hypersensitivity Syndromes, Drug,Syndrome, Drug Hypersensitivity,Syndromes, Drug Hypersensitivity

Related Publications

S Ingen-Housz-Oro, and T-A Duong, and N de Prost, and A Colin, and L Fardet, and B Lebrun-Vignes, and A Barbaud, and O Chosidow, and P Wolkenstein, and
July 2016, The Journal of dermatology,
S Ingen-Housz-Oro, and T-A Duong, and N de Prost, and A Colin, and L Fardet, and B Lebrun-Vignes, and A Barbaud, and O Chosidow, and P Wolkenstein, and
October 2013, Medical journal, Armed Forces India,
S Ingen-Housz-Oro, and T-A Duong, and N de Prost, and A Colin, and L Fardet, and B Lebrun-Vignes, and A Barbaud, and O Chosidow, and P Wolkenstein, and
October 2017, The Medical journal of Australia,
S Ingen-Housz-Oro, and T-A Duong, and N de Prost, and A Colin, and L Fardet, and B Lebrun-Vignes, and A Barbaud, and O Chosidow, and P Wolkenstein, and
January 2017, Journal of immunology research,
S Ingen-Housz-Oro, and T-A Duong, and N de Prost, and A Colin, and L Fardet, and B Lebrun-Vignes, and A Barbaud, and O Chosidow, and P Wolkenstein, and
April 2022, Australian prescriber,
S Ingen-Housz-Oro, and T-A Duong, and N de Prost, and A Colin, and L Fardet, and B Lebrun-Vignes, and A Barbaud, and O Chosidow, and P Wolkenstein, and
April 2014, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
S Ingen-Housz-Oro, and T-A Duong, and N de Prost, and A Colin, and L Fardet, and B Lebrun-Vignes, and A Barbaud, and O Chosidow, and P Wolkenstein, and
January 2015, Indian journal of dermatology,
S Ingen-Housz-Oro, and T-A Duong, and N de Prost, and A Colin, and L Fardet, and B Lebrun-Vignes, and A Barbaud, and O Chosidow, and P Wolkenstein, and
January 2011, Indian journal of dermatology, venereology and leprology,
S Ingen-Housz-Oro, and T-A Duong, and N de Prost, and A Colin, and L Fardet, and B Lebrun-Vignes, and A Barbaud, and O Chosidow, and P Wolkenstein, and
April 2024, Nature reviews. Disease primers,
S Ingen-Housz-Oro, and T-A Duong, and N de Prost, and A Colin, and L Fardet, and B Lebrun-Vignes, and A Barbaud, and O Chosidow, and P Wolkenstein, and
April 2024, Nature reviews. Disease primers,
Copied contents to your clipboard!